Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

Area of Science:

• Cardiovascular physiology
• Neuroscience
• Pharmacology

Background:

• The sympathetic nervous system regulates cardiovascular function via adrenergic receptors.
• Alpha2-adrenergic receptors are crucial for regulating neurotransmitter release from sympathetic and central nervous system neurons.
• The specific roles of alpha2A, alpha2B, and alpha2C adrenergic receptor subtypes in this regulation are not fully understood.

Purpose of the Study:

• To investigate the distinct roles of alpha2A, alpha2B, and alpha2C adrenergic receptor subtypes in regulating neurotransmitter release.
• To determine the physiological consequences of disrupting these receptor subtypes on cardiovascular function.

Main Methods:

• Gene disruption in mice to create knockout models for each alpha2-adrenergic-receptor subtype.
• Measurement of neurotransmitter release from sympathetic nerves and central noradrenergic neurons.
• Assessment of plasma noradrenaline concentrations and cardiac function (cardiac hypertrophy, left ventricular contractility).

Main Results:

• Both alpha2A- and alpha2C-adrenergic receptor subtypes are essential for normal presynaptic control of neurotransmitter release.
• Alpha2A receptors inhibit transmitter release at high stimulation frequencies.
• Alpha2C receptors modulate neurotransmission at lower nerve activity levels.
• Mice lacking both alpha2A and alpha2C subtypes exhibit elevated plasma noradrenaline and develop cardiac hypertrophy with reduced contractility.

Conclusions:

• Alpha2A and alpha2C adrenergic receptors play distinct but complementary roles in regulating sympathetic neurotransmission.
• Disruption of these receptors has significant detrimental effects on cardiovascular homeostasis.
• Understanding these subtype-specific functions is critical for developing targeted therapies for cardiovascular and neurological disorders.